TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T08156 XX ID T08156 XX DT 19.04.2016 (updated); hna. CO Copyright (C), QIAGEN. XX FA BCL-6 XX SY B-cell lymphoma 6 protein homolog; BCL-6; BCL6. XX OS mouse, Mus musculus OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; rodentia; myomorpha; muridae; murinae XX GE G005083 Bcl6. XX CL C0001; CH; 2.3.3.22.2. XX FF repression [2]; FF accelerated Blimp1 mRNA induction and plasmacytic differentiation in the absence of Bcl-6 [2]; XX MX M01183 V$BCL6_01. MX M01185 V$BCL6_02. MX M07077 V$BCL6_03. MX M01171 V$BCL6_Q3. MX M02085 V$BCL6_Q3_01. MX M07375 V$BCL6_Q6. XX BS R30894. BS R42486. BS R65917. BS R65918. BS R72839. BS R72840. BS R72837. BS R72838. BS R30895. BS R36623. BS R72825. BS R72826. BS R71267. XX DR TRANSPATH: MO000001616. DR UniProtKB: P41183; XX RN [1]; RE0053025. RX PUBMED: 15567177. RA Suzuki H., Kurita M., Mizumoto K., Moriyama M., Aiso S., Nishimoto I., Matsuoka M. RT The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression. RL Biochem. Biophys. Res. Commun. 326:242-248 (2005). RN [2]; RE0035365. RX PUBMED: 15240705. RA Tunyaplin C., Shaffer A. L., Angelin-Duclos C. D., Yu X., Staudt L. M., Calame K. L. RT Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. RL J. Immunol. 173:1158-1165 (2004). XX //